peripartum cardiomyopathy

32
PERIPARTUM CARDIOMYOPATHY DR.T.NEELAMBUJAN,M.D.,DNB(CARDIO)., CONSULTANT CARDIOLOGIST & INTERVENTIONALIST SUNDARAM ARULRHAJ HOSPITAL TUTICORIN

Upload: rizki-amalia

Post on 19-Jul-2016

38 views

Category:

Documents


2 download

DESCRIPTION

kardio

TRANSCRIPT

Page 1: Peripartum Cardiomyopathy

PERIPARTUM CARDIOMYOPATHY

DR.T.NEELAMBUJAN,M.D.,DNB(CARDIO).,CONSULTANT CARDIOLOGIST & INTERVENTIONALIST

SUNDARAM ARULRHAJ HOSPITALTUTICORIN

Page 2: Peripartum Cardiomyopathy

DYSPNEA – POST PARTUM

35/F – DOE ; 3 WKS AFTER DELIVERY HTN DURING PREGNANCY NO CARDIOVASCULAR DISEASE O/E : B.P 110/70 mm Hg ; PR 105 /min LOW

VOL PERIPHERAL PULSES WELL FELT RR 28/min. JVP 10 cm ;PEDAL EDEMA Grade II PANSYSTOLIC MURMUR LVS3 + BILATERAL RALES

Page 3: Peripartum Cardiomyopathy

LIKELY CAUSES?

PERIPARTUM CMP

PULMONARY EMBOLISM

AORTIC DISSECTION

ACUTE MI

ANAEMIA WITH HF

Page 4: Peripartum Cardiomyopathy

ECHO

Page 5: Peripartum Cardiomyopathy

PERIPARTUM CARDIOMYOPATHY

DEMAKIS et al- 1971 NAMED DCM WITH SIGNS OF HF IN THE

LAST MONTH OF PREGNANCY OR WITHIN

5 MONTHS OF DELIVERY

INCIDENCE VARIES

Page 6: Peripartum Cardiomyopathy

TIMING OF DIAGNOSIS

DX. REQUIRES BEING IN THE LAST MONTH OF PREGNANCY

IF EARLIER, CONSIDER OTHER HEART DISEASE (ISCHEMIC, VALVULAR, OR MYOPATHIC)

2ND TRIMESTER BURDEN

Page 7: Peripartum Cardiomyopathy

WHAT CAUSES IT?

• OLDEST THEORY

• ENDOMYOCARDIAL BIOPSY

• VARIABLE PREVALENCE

MYOCARDITIS

Page 8: Peripartum Cardiomyopathy

PATHOLOGIC IMMUNE RESPONSE VIRAL INFECTION & PATHOLOGIC IMMUNE

RESPONSE AGAINST VIRAL ANTIGENS

CROSS REACTS WITH NATIVE CARDIAC TISSUE PROTEINS

PARVOVIRUS B19; HUMAN HERPES VIRUS 6; EBV; CMV

Page 9: Peripartum Cardiomyopathy

CHIMERISM

CELLS FROM FETUS COLONIZE IN MOTHER PROVOKING IMMUNE RESPONSE

AUTOANTIBODIES AGAINST CARDIAC TISSUE PROTEINS IN HIGH TITRES APOPTOSIS

APOPTOSIS OF CARDIAC MYOCYTES

ROLE OF Fas and Fas LIGAND

Page 10: Peripartum Cardiomyopathy

ROLE OF PROLACTIN

• CARDIOMYOCYTE DELETION OF stat3

• ENHANCED CARDIAC CATHEPSIN D

• PROTEOLYTIC CLEVAGE OF PROLACTIN INTO 16KDa PRL FRAGMENT

• 16KDa PRL FRAGMENT- PROINFLAMMATORY,

PROAPOPTOTIC & ANTIANGIOGENIC

Page 11: Peripartum Cardiomyopathy

OTHER POSSIBLE FACTORS

SELENIUM DEFICIENCY RELAXIN CARDIAC DYSTROPHIN IMMATURE DENDRITIC CELLS CARDIAC NO SYNTHASE HARMONE- PROGEST,PRL,OESTROGEN HAEMODYNAMIC STRESS OF

PREGNANCY FAMILIAL

Page 12: Peripartum Cardiomyopathy

WHO IS AT RISK?

●AGE >30 YEARS ●MULTIPARITY●MULTIFETAL PREGNANCY●GESTATIONAL HTN●LONG TERM TOCOLYTIC Rx

●RACIAL●COCAINE ABUSE

Page 13: Peripartum Cardiomyopathy

CLINICAL PRESENTATION

SYMPTOMSPNDDOECOUGHORTHOPNEACHEST PAINABD DISCOMFORTPALPITATIONTHROMBOEMBOLIS

MHAEMOPTYSISSCD

SIGNSCARDIOMEGALYGALLOP RHYTHMEDEMAMURMUR

UNEXPLAINED SYMPTOMS

HEIGHTENED SUSPICION

LATENT CMP

Page 14: Peripartum Cardiomyopathy

ECHOCARDIOGRAM

• SPHERICAL LV• MITRAL AND

TRICUSPID REGURGITATION

• LEFT ATRIAL ENLARGEMENT

• EF <45%

Page 15: Peripartum Cardiomyopathy

LABORATORY EVALUATION

HB

RENAL PARAMETERS

ELECTROLYTES & CALCIUM

TSH

BNP LEVELS

TROPONIN LEVELS

Page 16: Peripartum Cardiomyopathy

ECG

• SINUS TACHYCARDIA

• NONSPECIFIC ST CHANGES

• LVH

Page 17: Peripartum Cardiomyopathy

CHEST X-RAY

• PULMONARY EDEMA

• VENOUS CONGESTION

• CARDIOMEGALY

Page 18: Peripartum Cardiomyopathy

CARDIAC MRI

♠ DELAYED CONTRAST ENCHANCEMENT (GADOLINIUM)

♠ CHARACTERIZE MYOCARDIUM & DIFFERENTIATE TYPE OF MYOCYTE NECROSIS

♠ GUIDE BIOPSY

♠ ASSESS LV FUNCTION

Page 19: Peripartum Cardiomyopathy

HEART FAILURE Rx – PREGNANCY

♣ WELFARE OF FETUS & MOTHER♣ CO-ORDINATED MANAGEMENT♣ FETAL HEART MONITORING-

ADVISABLE♣ ACEI & ARBs -CONTRAINDICATED♣ DIG,BB,NITRATES & HYDRALAZINE-

SAFE♣ LOOP DIURETICS-CAUTIOUS USE♣ ELECTIVE LSCS-MOST CASES

Page 20: Peripartum Cardiomyopathy

HEART FAILURE Rx- POSTPARTUM

♥ IDENTICAL TO NONPREG WITH DCM

♥ DIURETICS – SYMPTOM RELIEF

♥ DIGOXIN – REDUCES HOSPITALISATION

♥ ACEI & ARBs – MAXIMUM DOSE

♥ BB-CARVEDILOL & METAPROLOL

♥ HOW LONG TO TREAT?

Page 21: Peripartum Cardiomyopathy

ANTICOAGULATION

► RISK OF THROMBOEMBOLISM HIGH

► ARTERIAL,VENOUS & CARDIAC

► WHO SHOULD RECEIVE ? SEVERE LV DYSFUNCTION DOCUEMENTED LV CLOT H/O SYSTEMIC EMBOLISM AF

Page 22: Peripartum Cardiomyopathy

WARFARIN & HEPARIN

☻ WARFARIN SAFE AFTER FIRST TRIMESTER

☻ SWITCH TO UFH FOR PLANNED DELIVERY

☻ UNPLANNED DELIVERY ON WARF-LSCS

☻ MONITOR PT/INR VALUES

☻ ROLE OF DABIGATRAN

Page 23: Peripartum Cardiomyopathy

NEWER TREATMENT

IV IMMUNOGLOBULINS IMMUNOSUPPRESSIVE BROMOCRIPTINE MONOCLONAL ANTIBODIES INTERFERON BETA THERAPEUTIC APHERESIS NONSPECIFIC IMMUNOADSORPTION

Page 24: Peripartum Cardiomyopathy

IABP

Page 25: Peripartum Cardiomyopathy

ECMO

Page 26: Peripartum Cardiomyopathy

NATURAL COURSE

♦ BETTER SURVIVAL RATES

♦ 94% SURVIVAL AT 5 YEARS

♦ 54% RECOVERED NORMAL LV FUNCTION ( Elkayam et al )

♦ LV FUNCTION RECOVERS > 6 MONTHS

♦ RECOVERY MORE LIKELY -LVEF > 30%

Page 27: Peripartum Cardiomyopathy

CRT

Page 28: Peripartum Cardiomyopathy

ARTIFICIAL HEART CARDIAC TRANSPLANT

Page 29: Peripartum Cardiomyopathy

POOR PROGNOSTIC FACTORS♪ HIGH TROPONIN T LEVELS

♪ QRS DURATION > 120 ms

♪ LVEF < 30%

♪ LVIDs > 5.5 cms

♪ FS > 20%

♪ LV THROMBUS

♪ RACE

Page 30: Peripartum Cardiomyopathy

RISK OF RELAPSE?♥ LV FUNCTION COMPLETE RECOVERY- PREG NOT CONTRAINDICATED ( LOW

RISK )

♥ LV FUNCTION PARTIAL RECOVERY-DSE

♥ DSE NORMAL-PREG NOT CONTRAINDICATED

♥ DSE ABNORMAL-PREG NOT RECOMMENDED

♥ LV FUNCTION NOT RECOVERED-PREGNANCY CONTRAINDICATED (HIGH RISK)

Page 31: Peripartum Cardiomyopathy

POORLY UNDERSTOOD DISEASE

HEIGHTENED SUSPICION FOR EARLY DIAGNOSIS

AGGRESSIVE ACUTE MANAGEMENT

RELAPSE- ACHILLES HEEL

HOPEFUL OPTIONS FOR CHRONIC HF

Page 32: Peripartum Cardiomyopathy

THANK YOU